Characterization of oligoadenylate synthetase-1 expression in rat mammary gland and prostate: effects of 17beta-estradiol on the regulation of OAS1g in both tissues.

Molecular and Cellular Biochemistry
C J B MaiaC R A Santos

Abstract

OAS1 belongs to a protein family of interferon-induced enzymes characterized by their ability to catalyze the synthesis of 2'-5'-linked oligomers of adenosine from ATP (2-5A). 2-5A bind to the latent Ribonuclease L (RNase L), which subsequently dimerizes into the active form, acquiring the capacity of cleaving cellular and viral mRNA. Several studies indicate that OAS1 is an important inducer of apoptosis in human cancer cells and that it may be regulated by 17beta-estradiol (E(2)). The aim of this study was to characterize OAS1 gene expression in rat mammary gland and prostate, and to analyze its regulation by E(2) in both tissues. It is demonstrated that OAS1g is the most abundant OAS1 gene expressed in both tissues, and that OAS1 protein is present in the nucleus of rat mammary gland and prostate epithelial cells. In addition, it is shown by Real Time PCR that OAS1g is up-regulated by E(2) in rat mammary gland, but down-regulated in prostate, suggesting that the OAS1g gene may be related to estrogen dependent pathways in rat mammary gland and prostate physiology.

References

Jan 1, 1989·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·L SilvestroE Genazzani
Aug 1, 1986·Biochimica Et Biophysica Acta·M SmekensP Galand
Feb 24, 1995·The Journal of Biological Chemistry·B Dong, R H Silverman
Apr 14, 1999·Cell Death and Differentiation·J C CastelliR J Youle
May 20, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D Rebouillat, A G Hovanessian
Aug 28, 1999·The Journal of Biological Chemistry·S N SarkarG C Sen
Jun 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrey A PerelyginMargo A Brinton
Sep 12, 2002·Cellular and Molecular Life Sciences : CMLS·S EskildsenJ Justesen
Oct 25, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Shigeru KakutaYoichiro Iwakura
Jun 26, 2003·Nucleic Acids Research·Elisabeth GasteigerAmos Bairoch
Jan 25, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Pirkko L Härkönen, Sari I Mäkelä
Dec 26, 2006·Breast Cancer Research and Treatment·Nedret AltiokSoner Altiok
Apr 24, 2007·Biochemistry. Biokhimii︠a︡·Yu S LobanovaM A Krasil'nikov

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis